Allozymes raised $15M in a series A to grow its business and expand its enzyme-tailoring services.

Allozymes has raised a $15 million series A funding round to expand its business and accelerate the screening of enzyme variants, aiming to reach 20 million variants per day. The company plans to offer more from-scratch work and expand its enzyme-tailoring services to fulfill a wider range of needs.